💬 Opinion 6h ago · David Mansdoerfer, opinion contributor

View Channel →

0 0 Save Read Full Article Source ↗ 👁 0 💬 0

Former official David Mansdoerfer argues that bureaucratic delays at the FDA threaten American leadership in the growing regenerative medicine sector and give international competitors like China a strategic advantage.

Sign in to join the discussion

📰

Suit Alleging Medical Establishment's Desire to Compel Doctors "to Toe the Line in All Matters Related to COVID …" Can Go Forward

Reason.com · 3h ago

David Wallace-Wells: The Politics of AI Are Shifting in Real Time

The Bulwark · 3h ago

The DSA Is Fully Aware Of The Horrors Of Socialism, But They Don’t Care As Long As They Get Power

The Federalist · 3h ago

📰

"Yes, I'm with … Hamas and Hezbollah and Islamic Jihad but up to a Point" Visiting Prof's Suit Against Columbia Dismissed

Reason.com · 3h ago

Trump Is Taking Credit for D.C.'s Crime Drop. Here's What the Data Say.

Reason.com · 3h ago

Justice Department Finds 'Unbroken Pattern' of Sexual Abuse in Two California Women's Prisons

Reason.com · 4h ago